Axsome Therapeutics (AXSM) Work In Process (2022 - 2025)
Historic Work In Process for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $12.9 million.
- Axsome Therapeutics' Work In Process rose 5687.26% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 5687.26%. This contributed to the annual value of $7.7 million for FY2024, which is 2492.47% down from last year.
- Latest data reveals that Axsome Therapeutics reported Work In Process of $12.9 million as of Q3 2025, which was up 5687.26% from $7.5 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Work In Process ranged from a high of $14.0 million in Q4 2022 and a low of $6.8 million during Q1 2025
- In the last 4 years, Axsome Therapeutics' Work In Process had a median value of $10.3 million in 2023 and averaged $10.1 million.
- Over the last 5 years, Axsome Therapeutics' Work In Process had its largest YoY gain of 5687.26% in 2025, and its largest YoY loss of 3763.65% in 2025.
- Axsome Therapeutics' Work In Process (Quarter) stood at $14.0 million in 2022, then fell by 26.34% to $10.3 million in 2023, then fell by 24.92% to $7.7 million in 2024, then soared by 66.4% to $12.9 million in 2025.
- Its Work In Process stands at $12.9 million for Q3 2025, versus $7.5 million for Q2 2025 and $6.8 million for Q1 2025.